Patrocinados
What is Leqembi? The first Alzheimer’s treatment approved today in Saudi Arabia
Posted
Saudi Arabia’s SFDA has approved Leqembi (lecanemab), the Kingdom’s first Alzheimer’s treatment. This innovative drug slows disease progression by targeting beta-amyloid plaques, protein clumps that disrupt brain cell communication. Approved for patients with mild symptoms and specific genetic profiles, Leqembi requires careful monitoring to manage side effects, marking a major step forward in Alzheimer’s care through advanced biotechnology.
Buscar
Categorías
- National
- International
- Business
- Technology
- Health
- Educación
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Read More
Ishita Dutta shares health update from hospital bed with son Vaayu
Ishita Dutta revealed a challenging period where both she and her son Vaayu were hospitalised,...
'I had suicidal thoughts': Chahal breaks silence on divorce, mental health battle
Yuzvendra Chahal revealed the emotional distress and mental health challenges he faced during his...
US mortgage rate shift: 30-year home loan eases to 6.72% after Fed decision; housing demand stays weak
US mortgage rates saw a slight dip this week, with the 30-year fixed rate averaging 6.72%, a...
Trump's Pak oil deal a move to counter China, pressure India?
Donald Trump's announcement of a deal to develop Pakistan's oil reserves is viewed with...
© 2025 Dununu.com : Circle of Life - Santan Social Network
Spanish
